Offer - Urjas Oil for just ₹ 1 X
Montelukast + Rupatadine is an allopathic medicine The correct dosage of Montelukast + Rupatadine depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Montelukast + Rupatadine is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Montelukast + Rupatadine is used -
Severe
Moderate
Mild
Common
Is the use of Montelukast + Rupatadine safe for pregnant women?
Montelukast + Rupatadine has little to no side effects in pregnant women.
Is the use of Montelukast + Rupatadine safe during breastfeeding?
Montelukast + Rupatadine may have very limited harmful effects for breastfeeding women.
What is the effect of Montelukast + Rupatadine on the Kidneys?
Montelukast + Rupatadine may have mild side effects on the kidneys.
What is the effect of Montelukast + Rupatadine on the Liver?
Montelukast + Rupatadine may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Montelukast + Rupatadine on the Heart?
Very few cases of side effects of Montelukast + Rupatadine on the heart have been reported.
Montelukast + Rupatadine should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Montelukast + Rupatadine unless your doctor advises you to do so -
Is this Montelukast + Rupatadine habit forming or addictive?
Montelukast + Rupatadine is not addictive in nature.
Interaction between Food and Montelukast + Rupatadine
It is safe to take Montelukast + Rupatadine with food.
Interaction between Alcohol and Montelukast + Rupatadine
Taking alcohol with Montelukast + Rupatadine can be dangerous.
Yes, Montelukast + Rupatadine help with COPD (chronic obstructive pulmonary disease). Montelukast + Rupatadine block the action of leukotriene which is responsible for narrowing the airways. By blocking the leukotriene Montelukast + Rupatadine prevents the narrowing of airways.
Yes, Montelukast + Rupatadine causes dry mouth because it decreases the saliva secretion in your mouth. It is an uncommon side effect of this drug. If you experience excess dry mouth after taking this drug, keep yourself hydrated with juices, shakes and ample water.
Yes, Montelukast + Rupatadine can be taken with paracetamol (acetaminophen). No harmful drug interaction has been reported between them. However, if you feel any unpleasant effects then consult your doctor and follow his/her instructions.
Yes, Montelukast + Rupatadine causes drowsiness. It is the most common side effect of this medicine. You are recommended to not drive any vehicle or operate machinery after taking this medicine as it causes drowsiness.
No, Montelukast + Rupatadine should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Rupatadine
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167